GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Tevogen Bio Holdings Inc (FRA:G28) » Definitions » Price-to-Funds-From-Operations

Tevogen Bio Holdings (FRA:G28) Price-to-Funds-From-Operations : (As of Apr. 01, 2025)


View and export this data going back to 2024. Start your Free Trial

What is Tevogen Bio Holdings Price-to-Funds-From-Operations?

Price-to-Funds-From-Operations only applies to REITs.


Tevogen Bio Holdings Business Description

Traded in Other Exchanges
Address
15 Independence Boulevard, Warren, NJ, USA, 07059
Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes ("CD8+ CTLs" or "CTLs"), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders.